Origin Endoscopy offers medical products to control the hemostatic effects of gastrointestinal bleeding during endoscopy procedures.
Origin Endoscopy has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Origin Endoscopy is headquartered in Englewood, United States.
Origin Endoscopy offers medical products to control the hemostatic effects of gastrointestinal bleeding during endoscopy procedures.
Origin Endoscopy is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Origin Endoscopy — Funding & Investors." VCBacked, October 2, 2024, https://www.vcbacked.co/company/origin-endoscopy. Accessed September 30, 2026.
VCBacked. (2024). Origin Endoscopy — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/origin-endoscopy
{{cite web |title=Origin Endoscopy — Funding & Investors |url=https://www.vcbacked.co/company/origin-endoscopy |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated